Adaptive Care Transition Strategy Sprint — Christine Galligan
Kutuhala Studio · Post-Acute Care · Readmissions

The 30-day blindness.

Hospital discharge hands the hardest month of care to a family member you can't see. Caregiver capacity is a clinical signal — and it's predictable.

Adaptive Care Transition Strategy Sprint · 14 weeks See expected outcomes ↓
01

The gap

Visible in hospital. Invisible at home. Preventable at escalation.

20–25%
of Medicare discharges readmit within 30 days
30–40%
of readmissions are caregiver-driven
48–72h
early-warning window before escalation (under test)
02

Why it's missed

Discharge planning treats caregivers as logistics. Rides arranged. Prescriptions filled. Appointments scheduled. Necessary — and not the problem.

Caregiver capacity is a nervous-system problem: chronic load, silent until it isn't. From the hospital's side, escalation looks sudden. From the home, it was visible for days. Nobody was measuring the right thing.
03

The approach

Three moves, one integrated readmissions program.

Map the actual discharge-to-day-30 path inside your system: handoffs, blind spots, moments a caregiver holds a clinical decision without training.

Who is at highest risk of escalation, and when — read from light-touch signals patients already generate. Nothing new to buy, connect, or install.

Low-friction, staff-deliverable interventions triggered when the data says it matters — not on a fixed schedule, not another app.

04

The engagement · 14 weeks

Weeks 1–2

Discovery

Executive alignment, workflow shadowing, data access, target discharge cohort defined.

Weeks 2–6

Proof

50–100 caregivers followed through the 30-day window via light-touch signals plus friction logging. First live readings of caregiver load.

Weeks 5–8

Design

Intervention design tied to the signal: what triggers, who delivers it, how it lands inside existing staff workflow.

Weeks 8–14

Results

Outcome measurement, ROI model, and a publication-ready case study you own and can replicate across service lines.

Phases overlap by design — design work begins while the proof cohort is still running.

Discovery is also available standalone — a two-week engagement ending in a defined cohort, a mapped workflow, and a go / no-go decision you can defend internally.

05

Expected outcomes

15–25%
reduction in 30-day readmission rate
1.6–2.4×
return, paid back within the first quarter of scaling

Figures illustrative, pending first pilot. One publication-ready case study and a replicable blueprint you own either way.

06

Who's doing the work

Fifteen years inside healthcare's hardest transitions. Christine Galligan, MHA — work spanning Philips, CVS Health innovation, and multi-year caregiver stress research. Behavioral-science rigor combined with the operational reality of moving programs through a health system, from executive sponsorship to frontline adoption.

CVS Health — pilots serving 70M+ members, 15%+ adherence lift Philips — 20+ health technology ventures supported SOMA Systems — patent-pending adaptive-intelligence platform

This engagement is designed to reduce your risk: a defined 14-week scope, cohort-level proof before scale, and outputs your team owns and can defend internally.

Let's prove it works for your population.

Twenty minutes. One conversation about your discharge cohort, your current readmission numbers, and whether this engagement fits.

Book a call →